ArticleJPRAS open2025
Fibrinogen-to-albumin ratio (FAR) for predicting microvascular flap complications in reconstructive surgery.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Microvascular flap surgery is a widely used procedure for the reconstruction of various defects. Data on laboratory biomarkers for the prediction of flap complications are currently limited. We aimed to investigate the link between preoperative fibrinogen-to-albumin ratio (FAR) and various flap complications. Methods: This prospective cohort study included 130 adult patients who underwent elective microvascular flap surgery. Preoperative blood samples for the analysis of plasma fibrinogen (g/L) and albumin (g/L) were collected on the day of surgery before initiating crystalloid infusion. Post-operative data on various flap complications were obtained. Results: The overall complication rate was 17.7% with true flap loss occurring in 5.4%. Binary logistic regression revealed that the patients with FAR<0.08 and FAR<0.06 had increased odds of flap hematoma or flap loss (OR 3.68 [1.04-13.03], p=0.044 and 6.01 [1.71-21.08], p=0.005). Patients with FAR>0.10 had increased odds of minor flap complications (OR 5.47 [1.33-22.50], p=0.019). Patients with FAR<0.06 had increased odds of any flap complications (OR 4.71 [1.27-18.03], p=0.021). Patients with FAR>0.10 also had increased odds of any flap complications (OR 3.09 [1.08-8.81], p=0.035), implying a U-shaped link. Conclusions: Assessment of FAR to estimate the risk of complications has considerable predictive value in microvascular flap surgery. Patients undergoing this surgery can be evaluated to predict their nutrition and coagulation risks and optimize decision-making in their perioperative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.